Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden
· Delayed Price · Currency is SEK 6.00
-0.07 (-1.15%)
At close: Mar 6, 2026
Cereno Scientific AB Revenue
In the year 2025, Cereno Scientific AB had annual revenue of 44.27M SEK, down -45.28%. Cereno Scientific AB had revenue of 9.72M in the quarter ending December 31, 2025, a decrease of -16.04%.
Revenue
44.27M
Revenue Growth
-45.28%
P/S Ratio
40.74
Revenue / Employee
4.43M
Employees
10
Market Cap
1.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.27M | -36.63M | -45.28% |
| Dec 31, 2024 | 80.90M | 31.63M | 64.18% |
| Dec 31, 2023 | 49.28M | -8.26M | -14.36% |
| Dec 31, 2022 | 57.54M | 12.73M | 28.42% |
| Dec 31, 2021 | 44.81M | 36.58M | 444.85% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 425.75M |
| Orexo AB | 26.00M |
| Cinclus Pharma Holding AB | 57.47M |
| Nanexa AB | 55.94M |
| Dicot Pharma AB | 200.00K |
| Enzymatica AB | 53.90M |
| Moberg Pharma AB | 13.54M |
| BioGaia AB | 1.54B |